Clinical Observation Of Liujunzi Decoction In Treating Bronchial Dilatation With Deficiency Of Lung And Spleen Qi In Stable Stage

Objective: In this study,we examined if thesymptoms of Liu Jun Zi oralis decoration clinics The function of pulmonary function and others in patients with bronchiectasis during the phase is stable with conventional clinical medicine Western efficiency.clinicale et securitas decorationis Liujun Zi in ārstatione stabilis bronchiectasis.Methods: In this study,60-patients meeting the diagnostic criteria were randomly divided into two groups after randomised controlled randomised controlled controlled trials and the treatment group was treated with Western medicine based on Western medicine.The Measures were grouped into two groups: and the clinical efficacy and safety assessment was performed in the group and in the group between the respective scales.Results: During the test,one control group patient withdrew from the test due to the reluctance to continue participating and control group included a total patient data 59.Analysis.It was not a difference between the two groups At the effective post-treatment rate,the treatment group significantly better than the group from Control.Treatment,total scores of TCM syndrome and individual items were better than before than before.treatment.Treatment,total symptom scores,cough,expectoration,burnout fatigue,self-sweating,As the effective rate,the treatment group improved better than the BSI Group control.FEV1%,FVC% were better after treatment than before treatment,but the difference between the two non-Era Security Groups significant.Indicators In both groups there was no difference in the contrast between groups before and after treatment.Conclusion: Compared to conventional Western medicine only to improve cough,expectoration,fatigue and spontaneous perspiration,the combination of liujunzi decoding and treatment with western medicine was higher,which significantly improved the main clinical symptoms of discomfort of patients visited the doctor,and had good clinical safety.The improvement of symptoms during the steady phase,which can optimise the quality of life of patients with bronchospasm,is worth pursuing.